From bench to bedside, and beyond
In the United States and abroad, Matthew Dolan ’81 has served as a leader in immunology and virology.
Capsid of HIV-1 behaves like cell’s cargo receptor to enter the nucleus
Biologists demonstrate that HIV-1 capsid acts like a Trojan horse to pass viral cargo across the nuclear pore.
3 Questions: Darrell Irvine on making HIV vaccines more powerful
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.
Deep learning helps predict new drug combinations to fight Covid-19
Neural network identifies synergistic drug blends for treating viruses like SARS-CoV-2.
Four researchers earn interdisciplinary Schmidt Science Fellowships
Selective global honor supports early-career scientists and engineers in taking on new pursuits.
Model analyzes how viruses escape the immune system
Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.
HIV genome bends over backwards to help virus take over cells
Differently shaped RNA molecules allow HIV to express different genes from the same RNA sequence.
Structure of T cell epitopes a decisive factor in natural HIV control, study finds
Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response.
New drug capsule may allow weekly HIV treatment
Replacing daily pills with a weekly regimen could help patients stick to their dosing schedule.
Course helps girls in Botswana avoid HIV and “sugar daddies”
Youth-to-youth program teaches girls about the increased odds of contracting HIV from older men.
Senior Kristen Finney and GlobeMed lend a helping hand
MIT students partner with a clinic in Togo to improve health care for HIV/AIDS patients.
Seeking rare cells
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.
Evaluating strategies for HIV vaccination
Study yields insight into generating antibodies that target different strains of HIV.
Forced mutations doom HIV
New study reveals how a potential HIV drug exacts its toll on viral populations.